Terms: = Pancreatic cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
228 results:
1. Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy.
Li YS; Ye LY; Luo YX; Zheng WJ; Si JX; Yang X; Zhang YN; Wang SB; Zou H; Jin KT; Ge T; Cai Y; Mou XZ
Acta Biomater; 2024 Apr; 179():243-255. PubMed ID: 38458511
[TBL] [Abstract] [Full Text] [Related]
2. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial).
Zhu HD; Li X; Sun JH; Zhu X; Liu ZY; Li HL; Lu J; Yan ZP; Shao GL; He XF; Chao M; Lu LG; Zhong BY; Li R; Zhang Q; Teng GJ
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):325-336. PubMed ID: 38413420
[TBL] [Abstract] [Full Text] [Related]
3. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
4. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules.
Hu J; Jiang J; Xu B; Li Y; Wang B; He S; Ren X; Shi B; Zhang X; Zheng H; Hua B; Liu R
J Ethnopharmacol; 2024 Mar; 322():117590. PubMed ID: 38113986
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic Metastasectomy in Pediatric Patients: An Observational Study.
Fleming AM; Mansfield SA; Jancelewicz T; Gosain A; Eubanks JW; Davidoff AM; Langham MR; Murphy AJ
J Pediatr Surg; 2024 Feb; 59(2):247-253. PubMed ID: 37980196
[TBL] [Abstract] [Full Text] [Related]
7. The Broad Spectrum of Paediatric pancreatic Disease: A Single-center 26-years Retrospective Review.
Alnagar A; Khamag O; Sharif K; Mirza DF; Ong EGP
J Pediatr Surg; 2024 Feb; 59(2):261-267. PubMed ID: 37957099
[TBL] [Abstract] [Full Text] [Related]
8. Sono-activated materials for enhancing focused ultrasound ablation: Design and application in biomedicine.
Liao M; Du J; Chen L; Huang J; Yang R; Bao W; Zeng K; Wang W; Aphan BC; Wu Z; Ma L; Lu Q
Acta Biomater; 2024 Jan; 173():36-50. PubMed ID: 37939816
[TBL] [Abstract] [Full Text] [Related]
9. Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Oh DY; He AR; Qin S; Chen LT; Okusaka T; Vogel A; Kim JW; Suksombooncharoen T; Lee MA; Kitano M; Burris H; Bouattour M; Tanasanvimon S; McNamara MG; Zaucha R; Avallone A; Tan B; Cundom J; Lee CK; Takahashi H; Ikeda M; Chen JS; Wang J; Makowsky M; Rokutanda N; Żotkiewicz M; Kurland JF; Cohen G; Valle JW
Future Oncol; 2023 Nov; 19(34):2277-2289. PubMed ID: 37746835
[TBL] [Abstract] [Full Text] [Related]
10. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
[TBL] [Abstract] [Full Text] [Related]
11. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
[TBL] [Abstract] [Full Text] [Related]
12. A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging.
Yao L; Zhang Z; Keles E; Yazici C; Tirkes T; Bagci U
Curr Opin Gastroenterol; 2023 Sep; 39(5):436-447. PubMed ID: 37523001
[TBL] [Abstract] [Full Text] [Related]
13. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T
Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955
[TBL] [Abstract] [Full Text] [Related]
14. Oral microbiome as a new research-target for supportive care and precision oncology.
Bruno JS; Fregnani ER
Curr Opin Oncol; 2023 Jul; 35(4):276-281. PubMed ID: 37222190
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant and neoadjuvant approaches in pancreatic cancer.
Conroy T; Lambert A; Ducreux M
Curr Opin Oncol; 2023 Jul; 35(4):326-333. PubMed ID: 37222189
[TBL] [Abstract] [Full Text] [Related]
16. Risk Factors for Postoperative Unfavorable Ambulatory Status After Spinal Surgery for Metastatic Spinal Tumor.
Yamada K; Yoshii T; Toba M; Kudo A; Egawa S; Matsukura Y; Hirai T; Inose H; Fushimi K; Okawa A
Spine (Phila Pa 1976); 2023 Oct; 48(20):1419-1426. PubMed ID: 37199435
[TBL] [Abstract] [Full Text] [Related]
17. Radiofrequency ablation for the management of pancreatic mass lesions.
Merchant AA; Goebel AM; Willingham FF
Curr Opin Gastroenterol; 2023 Sep; 39(5):448-454. PubMed ID: 37097824
[TBL] [Abstract] [Full Text] [Related]
18. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
[TBL] [Abstract] [Full Text] [Related]
19. Integrating Functional Imaging and Molecular Profiling for Optimal treatment Selection in Neuroendocrine Neoplasms (NEN).
Kong G; Boehm E; Prall O; Murray WK; Tothill RW; Michael M
Curr Oncol Rep; 2023 May; 25(5):465-478. PubMed ID: 36826704
[TBL] [Abstract] [Full Text] [Related]
20. Betulinic acid, a major therapeutic triterpene of Celastrus orbiculatus Thunb., acts as a chemosensitizer of gemcitabine by promoting Chk1 degradation.
Tao L; Zhou K; Zhao Y; Xia X; Guo Y; Gao Y; Peng G; Liu Y
J Ethnopharmacol; 2023 Jun; 309():116295. PubMed ID: 36813244
[TBL] [Abstract] [Full Text] [Related]
[Next]
